NYSE:TFX - Teleflex Stock Price, Forecast & News

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Teleflex announced a quarterly dividend on Thursday, February 20th. Shareholders of record on Monday, March 2nd will be given a dividend of $0.34 per share on Monday, March 16th. This represents a $1.36 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date of this dividend is Friday, February 28th. View Teleflex's Dividend History.

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings data on Thursday, February, 20th. The medical technology company reported $3.28 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $3.22 by $0.06. The medical technology company had revenue of $681 million for the quarter, compared to analyst estimates of $679.01 million. Teleflex had a net margin of 17.78% and a return on equity of 18.97%. The business's quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.77 earnings per share. View Teleflex's Earnings History.

Teleflex is scheduled to release their next quarterly earnings announcement on Thursday, May 7th 2020. View Earnings Estimates for Teleflex.

Teleflex issued an update on its FY20 earnings guidance on Thursday, February, 20th. The company provided earnings per share guidance of $12.50-12.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.68. The company issued revenue guidance of $2.764-2.790 billion, compared to the consensus revenue estimate of $2.78 billion.

10 analysts have issued 12-month target prices for Teleflex's stock. Their forecasts range from $378.00 to $450.00. On average, they anticipate Teleflex's share price to reach $413.73 in the next twelve months. This suggests a possible upside of 16.8% from the stock's current price. View Analyst Price Targets for Teleflex.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Teleflex.

News articles about TFX stock have trended somewhat positive recently, according to InfoTrie. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Teleflex earned a coverage optimism score of 1.0 on InfoTrie's scale. They also assigned media coverage about the medical technology company a news buzz of 8.0 out of 10, indicating that recent news coverage is very likely to have an impact on the stock's share price in the near term. View News Stories for Teleflex.

Teleflex saw a decline in short interest in January. As of January 31st, there was short interest totalling 638,200 shares, a decline of 15.6% from the January 15th total of 755,900 shares. Based on an average daily volume of 228,600 shares, the days-to-cover ratio is currently 2.8 days. Approximately 1.4% of the shares of the stock are sold short. View Teleflex's Current Options Chain.

Some companies that are related to Teleflex include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Steris (STE), Hologic (HOLX), Insulet (PODD) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include Visa (V), NVIDIA (NVDA), AbbVie (ABBV), Alibaba Group (BABA), Netflix (NFLX), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH), Lam Research (LRCX), ServiceNow (NOW) and ABIOMED (ABMD).

Teleflex's stock is owned by a variety of of retail and institutional investors. Top institutional investors include State Street Corp (4.12%), Janus Henderson Group PLC (1.95%), Marshall Wace LLP (1.57%), Geode Capital Management LLC (1.56%), William Blair Investment Management LLC (1.48%) and Goldman Sachs Group Inc. (1.24%). Company insiders that own Teleflex stock include Andrew A Krakauer, Benson Smith, Cameron P Hicks, George Babich Jr, John C Heinmiller, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle, Thomas Anthony Kennedy and Thomas E Powell. View Institutional Ownership Trends for Teleflex.

TFX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Marshall Wace LLP, Janus Henderson Group PLC, Rice Hall James & Associates LLC, Principal Financial Group Inc., Marshall Wace North America L.P., FIL Ltd and USS Investment Management Ltd. Company insiders that have sold Teleflex company stock in the last year include Benson Smith, Cameron P Hicks, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell. View Insider Buying and Selling for Teleflex.

TFX stock was acquired by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Montag & Caldwell LLC, Scout Investments Inc., AMI Asset Management Corp, Lord Abbett & CO. LLC, Victory Capital Management Inc., Kornitzer Capital Management Inc. KS and Victory Capital Management Inc.. Company insiders that have bought Teleflex stock in the last two years include Andrew A Krakauer and John C Heinmiller. View Insider Buying and Selling for Teleflex.

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TFX stock can currently be purchased for approximately $354.28.

Teleflex has a market capitalization of $16.42 billion and generates $2.60 billion in revenue each year. The medical technology company earns $461.47 million in net income (profit) each year or $11.15 on an earnings per share basis. Teleflex employs 15,200 workers across the globe.View Additional Information About Teleflex.

The official website for Teleflex is http://www.teleflex.com/.

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]